329 related articles for article (PubMed ID: 32694655)
21. Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen
Sisson HM; Fagerlund RD; Jackson SA; Briers Y; Warring SL; Fineran PC
Appl Environ Microbiol; 2024 Mar; 90(3):e0184623. PubMed ID: 38319087
[TBL] [Abstract][Full Text] [Related]
22. Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.
Oliveira H; São-José C; Azeredo J
Viruses; 2018 May; 10(6):. PubMed ID: 29844287
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria.
Gonçalves T; Marques AT; Manageiro V; Tanoeiro L; Vital JS; Duarte A; Vítor JMB; Caniça M; Gaspar MM; Vale FF
Int J Pharm; 2024 Feb; 651():123758. PubMed ID: 38160991
[TBL] [Abstract][Full Text] [Related]
24. DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N-Acetylmuramidase Activity.
Rodríguez-Rubio L; Gerstmans H; Thorpe S; Mesnage S; Lavigne R; Briers Y
Appl Environ Microbiol; 2016 Aug; 82(16):4975-81. PubMed ID: 27287318
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the efficacy of endolysins and membrane permeabilizers against Vibrio parahaemolyticus in marine conditions.
Zermeño-Cervantes LA; Martínez-Díaz SF; Venancio-Landeros AA; Cardona-Félix CS
Res Microbiol; 2023; 174(7):104104. PubMed ID: 37422006
[TBL] [Abstract][Full Text] [Related]
26. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
[TBL] [Abstract][Full Text] [Related]
28. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens.
Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M
J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934
[TBL] [Abstract][Full Text] [Related]
29. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84: defining a new endolysin catalytic subfamily.
Love MJ; Coombes D; Ismail S; Billington C; Dobson RCJ
Biochem J; 2022 Jan; 479(2):207-223. PubMed ID: 34935873
[TBL] [Abstract][Full Text] [Related]
30. Synthetic antimicrobial peptides as enhancers of the bacteriolytic action of staphylococcal phage endolysins.
Gouveia A; Pinto D; Veiga H; Antunes W; Pinho MG; São-José C
Sci Rep; 2022 Jan; 12(1):1245. PubMed ID: 35075218
[TBL] [Abstract][Full Text] [Related]
31. External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids.
Yan G; Yang R; Fan K; Dong H; Gao C; Wang S; Yu L; Cheng Z; Lei L
AMB Express; 2019 Jul; 9(1):106. PubMed ID: 31309363
[TBL] [Abstract][Full Text] [Related]
32. Peptidoglycan degrading activity of the broad-range Salmonella bacteriophage S-394 recombinant endolysin.
Legotsky SA; Vlasova KY; Priyma AD; Shneider MM; Pugachev VG; Totmenina OD; Kabanov AV; Miroshnikov KA; Klyachko NL
Biochimie; 2014 Dec; 107 Pt B():293-9. PubMed ID: 25241254
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the engineered endolysin mtEC340M.
Wang JM; Seok SH; Yoon WS; Kim JH; Seo MD
Acta Crystallogr F Struct Biol Commun; 2023 May; 79(Pt 5):105-110. PubMed ID: 37132476
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria.
Bai J; Yang E; Chang PS; Ryu S
Enzyme Microb Technol; 2019 Sep; 128():40-48. PubMed ID: 31186109
[TBL] [Abstract][Full Text] [Related]
35. Gram-negative endolysins: overcoming the outer membrane obstacle.
Sisson HM; Jackson SA; Fagerlund RD; Warring SL; Fineran PC
Curr Opin Microbiol; 2024 Apr; 78():102433. PubMed ID: 38350268
[TBL] [Abstract][Full Text] [Related]
36. TSPphg Lysin from the Extremophilic Thermus Bacteriophage TSP4 as a Potential Antimicrobial Agent against Both Gram-Negative and Gram-Positive Pathogenic Bacteria.
Wang F; Ji X; Li Q; Zhang G; Peng J; Hai J; Zhang Y; Ci B; Li H; Xiong Y; Deng X; Lin L
Viruses; 2020 Feb; 12(2):. PubMed ID: 32050494
[TBL] [Abstract][Full Text] [Related]
37. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
[TBL] [Abstract][Full Text] [Related]
38. Endolysins of bacteriophage vB_Sal-S-S10 can naturally lyse Salmonella enteritidis.
Wang X; Han L; Rong J; Ren H; Liu W; Zhang C
BMC Vet Res; 2022 Nov; 18(1):410. PubMed ID: 36411417
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.
Lai MJ; Lin NT; Hu A; Soo PC; Chen LK; Chen LH; Chang KC
Appl Microbiol Biotechnol; 2011 Apr; 90(2):529-39. PubMed ID: 21264466
[TBL] [Abstract][Full Text] [Related]
40. Bacteriophage-derived endolysins to target gram-negative bacteria.
Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY
Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
